UBS keeps Cerebras Systems at Buy but cuts price target to $155
UBS lowered its Cerebras Systems price target to $155 from $250 while keeping a Buy rating, according to TradingView citing Benzinga data.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
UBS kept its Buy rating on Cerebras Systems but reduced its price target by 38.0%, from $250 to $155. According to the TradingView report, the new target implies an upside of 58.6% from the November 12 close of $97.75.
Across the five most recent analyst notes over the past 30 days, price targets range from $175 to $250. Needham maintained Buy with a $200 target, Morgan Stanley kept Overweight at $178, Wedbush kept Outperform at $190, and TD Cowen kept Buy at $175.
why it matters
A single price target cut is routine, but the spread among brokers shows that analysts disagree on Cerebras's valuation. For most investors, the company's revenue trends and results will matter more than one note.
tags
instruments
sources
- UBS maintains Cerebras Systems at Buy, lowers price target to $155 from $250 — TradingView, 13 November 2026 at 16:52 UTC
- UBS maintains Vylor at Buy, lowers price target to $87 from $89 — TradingView, 13 November 2026 at 16:57 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗